Decrease in CD93 (C1qRp) expression in a human monocyte-like cell line (U937) treated with various apoptosis-inducing chemical substances

Microbiology and Immunology

Volumn 51, Issue 12, 2007, Pages 1189-1200

  Ikewaki, Nobunao ^a   Tamauchi, Hidekazu ^b   Inoko, Hidetoshi ^c  

^a KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Apoptosis inducing chemical substances; CD93 expression; U937 cells

Indexed keywords

7 AMINODACTINOMYCIN; CAMPTOTHECIN; CD18 ANTIGEN; CD93 ANTIGEN; COMPLEMENT COMPONENT C1Q; CYCLOHEXIMIDE; DACTINOMYCIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LIPOCORTIN 5; MITOMYCIN C; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL LINEAGE; CELL STRAIN U937; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOLECULAR SIZE; MONOCYTE; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; SUPERNATANT; UPREGULATION;

EID: 37549026796     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2007.tb04014.x     Document Type: Article

References (48)

1. Arribas, J., Coodly, L., Vollmer, P., Kishimoto, T.K., Rose-John, S., and Massagué, J. 1996. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J. Biol. Chem. 271: 11376-11382.
2. Bergeron, S., Beauchemin, M., and Bertrand, R. 2004. Camptothecin- and etoposide-induced apoptosis in human leukemia cells is independent of cell death receptor-3 and -4 aggregation but accelerates tumor necrosis factor-related apoptosis-inducing ligand-mediated cell death. Mol. Cancer Ther. 3: 1659-1669.
3. Bohlson, S.S., Silva, R., Fonseca, M.I., and Tenner, A.J. 2005. CD93 is rapidly shed from the surface of human myeloid cells and the soluble form is detected in human plasma. J. Immunol. 175: 1239-1247.
4. Bohlson, S.S., Zhang, M., Ortiz, C.E., and Tenner, A.J. 2005. CD93 interacts with the PDZ domain-containing adaptor protein GIPC: implications in the modulation of phagocytosis. J. Leukoc. Biol. 77: 80-89.
5. Carmona, E.M., Vassallo, R., Vuk-Pavlovic, Z., Standing, J.E., Kottom, T.J., and Limper, A.H. 2006. Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism. J. Immunol. 177: 459-467.
6. Chen, M., and Wang, J. 2002. Initiator caspases in apoptosis signaling pathways. Apoptosis 7: 313-319.
7. Danet, G.H., Luongo, J.L., Butler, G., Lu, M.M., Tenner, A.J., Simon, M.C., and Bonnet, D.A. 2002. C1qRp defines a new human stem cell population with hematopoietic and hepatic potential. Proc. Natl. Acad. Sci. U.S.A. 99: 10441-10445.
8. Dransfield, I., Buckle, A.M., Savill, J.S., McDowall, A., Haslett, C., and Hogg, N. 1994. Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression. J. Immunol. 153: 1254-1263.
9. Frumento, G., Ottonello, L., Bertolotto, M., Franchello, S., Melioli, G., and Dallegri, F. 2000. Spontaneous apoptosis in neutrophils is associated with downregulation of HLA Class I and is prevented by ligation of Class I. J. Leukoc. Biol. 68: 873-880.
10. Gitiin, C., Bayer, E.A., and Wilchek, M. 1987. Studies of biotin-binding site of avidin. Biochem. J. 242: 923-926.
11. Guo, L., Eisenman, J.R., Mahimkar, R.M., Peschon, J.J., Paxton, R.J., Black, R.A., and Johnson, R.S. 2002. A proteomic approach for the identification of cell-surface proteins shed by metalloproteases. Mol. Cell. Proteomics 1: 30-36
12. Hart, S.P., Ross, J.A., Ross, K., Haslett, C., and Dransfield, I. 2000. Molecular characterization of the surface of apoptotic neutrophils: implications for functional downregulation and recognition by phagocytes. Cell Death Differ. 7: 493-503.
13. Homburg, C.H., de Haas, M., von dem Borne, A.E., Verhoeven, A.J., Reutelingsperger, C.P., and Roos, D. 1995. Human neutrophils lose thek surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 85: 532-540.
14. Ikewaki, N., and Inoko, H. 1996. Development and characterization of a novel monoclonal antibody (mNI-11) that induces cell adhesion of the LPS-stimulated human monocyte-like cell line U937. J. Leukoc. Biol. 59: 697-708.
15. Ikewaki, N., Kulski, J.K., and Inoko, H. 2006. Regulation of CD93 cell surface expression by protein kinase C isoenzymes. Microbiol. Immunol. 50: 93-103.
16. Ikewaki, N., Sonoda, T., and Shibuya, A. 2006. Expression patterns of the C1qRp on the granulocytes and monocytes in peripheral blood mononuclear cells (PBMCs) from patients with liver diseases. J. of Kyushu Univ. of Health and Welfare 7: 183-189.
17. Jack, R.M., Lowenstein, B.A., and Nicholson-Weller, A. 1994. Regulation of C1q receptor expression on human polymorphonuclear leukocytes. J. Immunol. 153: 262-269.
18. Kageyama, A., Kusano, I., Tamura, T., Oda, T., and Muramatsu, T. 2002. Comparison of the apoptosis-inducing abilities of various protein synthesis inhibitors in U937 cells. Biosci. Biotechnol. Biochem. 66: 835-839.
19. Kim, T.-I., Tchah, H., Lee, S.-A., Sung, K., Beom Jin Cho, B.J., and Kook, M.S. 2003. Apoptosis in keratocytes caused by mitomycin C. Invest. Ophthalmol. Vis. Sci. 44: 1912-1917.
20. Kleeff, J., Kornmann, M., Sawhney, H., and Korc, M. 2000. Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells. Int. J. Cancer 86: 399-407.
21. Liao, P.C., and Lieu, C.H. 2005. Cell cycle specific induction of apoptosis and necrosis by paclitaxel in the leukemic U937 cells. Life Sci. 76: 1623-1639.
22. Ma, L., Xie, Y.-L., Yu, Y., and Zhang, Q.-N. 2005. Apoptosis of human gastric cancer SGC-7901 cells induced by mitomycin combined with sulindac. World J. Gastroenterol. 11: 1829-1832.
23. Maher, S., Toomey, D., Condron, C., and Bouchier-Hayes, D. 2002. Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumor counterattack. Immunol. Cell Biol. 80: 131-137.
24. Maruyama, H., Galvan, M., Waffarn, F., and Tenner, A.J. 2003. Human cord blood leukocyte innate immune responses to defense collagens. Pediatr. Res. 54: 724-731.
25. McGreal, E.P., Ikewaki, N., Akatsu, H., Morgan, B.P., and Gasque, P. 2002. Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q. J. Immunol. 168: 5222-5232.
26. Merlos-Suárez, A., Ruiz-Paz, S., Baselga, J., and Arribas, J. 2001. Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme. J. Biol. Chem. 276: 48510-48517.
27. Nagata, S., and Golstein, P. 1995. The Fas death factor. Science 267: 1449-1456.
28. Nakai, Y., Shiratsuchi, A., Manaka, J., Nakayama, H., Takio, K., Zhang, J.T., Suganuma, T., and Nakanishi, Y. 2005. Externalization and recognition by macrophages of large subunit of eukaryotic translation initiation factor 3 in apoptotic cells. Exp. Cell Res. 309: 137-148.
29. Nepomuceno, R.R., Henschen-Edman, A.H., Burgess, W.H., and Tenner, A.J. 1997. cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity 6: 119-129.
30. Nepomuceno, R.R., Ruiz, S., Park, M., and Tenner, A.J. 1999. C1qRP is a heavily O-glycosylated cell surface protein involved in the regulation of phagocytic activity. J. Immunol. 162: 3583-3589.
31. Norsworthy, P.J., Fossati-Jimack, L., Cortes-Hernandez, J., Taylor, P.R., Bygrave, A.E., Thompson, R.D., Nourshargh, S., Walport, M.J., and Botto, M. 2004. Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis. J. Immunol. 172: 3406-3414.
32. Nusbaum, P., Lainé, C., Seveau, S., Lesavre, P., and Halbwachs-Mecarelli, L. 2004. Early membrane events in polymorphonuclear cell (PMN) apoptosis: membrane blebbing and vesicle release, CD43 and CD16 down-regulation and phosphatidylserine externalization. Biochem. Soc. Trans. 32: 477-479.
33. Nusbaum, P., Lainé, C., Bouaouina, M., Seveau, S., Cramer, E.M., Masse, J.M., Lesavre, P., and Halbwachs-Mecarelli, L. 2005. Distinct signaling pathways are involved in leukosialin (CD43) down-regulation, membrane blebbing, and phospholipid scrambling during neutrophil apoptosis. J. Biol. Chem. 280: 5843-5853.
34. Onishi, Y., Azuma, Y., Sato, Y., Mizuno, Y., Tadakuma, T., and Kizaki, H. 1993. Topoisomerase inhibitors induce apoptosis in thymocytes. Biochim. Biophys. Acta 1175: 147-154.
35. Park, M., and Tenner, A.J. 2003. Cell surface expression of C1qRP/CD93 is stabilized by O-glycosylation. J. Cell. Physiol. 196: 512-522.
36. Philpott, N.J., Turner, A.J., Scopes, J., Westby, M., Marsh, J.C., Gordon-Smith, E.C., Dalgleish, A.G., and Gibson, F.M. 1996. The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood 87: 2244-2251.
37. 1 arrest followed by necrotic cell death. Cancer Res. 59: 3565-3569.
38. Seong, G.J., Park, C., Kim, C.Y., Hong, Y.J., So, H.-S., Kim, S.-D., and Park, R. 2005. Mitomycin-C induces the apoptosis of human tenon's capsule fibroblast by activation of c-Jun N-terminal kinase 1 and caspase-3 protease. Invest. Ophthalmol. Vis. Sci. 46: 3545-3552.
39. Shiratsuchi, A., Osada, S., Kanazawa, S., and Nakanishi, Y. 1998. Essential role of phosphatidylserine externalization in apoptosing cell phagocytosis by macrophages. Biochem. Biophys. Res. Commun. 246: 549-555.
40. Shiratsuchi, A., and Nakanishi, Y. 1999. Phosphatidylserine-mediated phagocytosis of anticancer drug-treated cells by macrophages. J. Biochem. 126: 1101-1106.
41. Solier, S., Lansiaux, A., Logette, E., Wu, J., Soret, J., Tazi, J., Bailly, C., Desoche, L., Solary, E., and Corcos, L. 2004. Topoisomerase I and II inhibitors control caspase-2 premessenger RNA splicing in human cells. Mol. Cancer Res. 2: 53-61.
42. Suzuki, A., and Kato, M. 1996. Chemotherapeutic agent CPT-11 induces the new expression of the apoptosis initiator to the cytoplasm. Exp. Cell Res. 227: 154-159.
43. Tenner, A.J. 1998. C1q receptors regulating specific functions of phagocytic cells. Immunobiology 199: 250-264.
44. Valente, P., Arzani, D., Cesario, A., Margaritora, S., Carbone, E., and Russo, P. 2003. TNF increases camptothecin-induced apoptosis by inhibition of NF-kappaB. Eur. J. Cancer 39: 1468-1477.
45. Walker, L.S., McLeod, J.D., Boulougouris, G., Patel, Y.I., Hall, N.D., and Sansom, D.M. 1998. Down-regulation of CD28 via Fas (CD95): influence of CD28 on T-cell apoptosis. Immunology 94: 41-47.
46. Walport, M.J., Davies, K.A., and Botto, M. 1998. C1q and systemic lupus erythematosus. Immunobiology 199: 265-285.
47. Webster, S.D., Park, M., Fonseca, M.I., and Tenner, A.J. 2000. Structural and functional evidence for microglial expression of C1qR(P), the C1q receptor that enhances phagocytosis. J. Leukoc. Biol. 67: 109-116.
48. Wu, R.C., Chen, D.F., Liu, M.J., and Wang, Z. 2004. Dual effects of cycloheximide on U937 apoptosis induced by its combination with VP-16. Biol. Pharm. Bull. 27: 1075-1080.